Confirmation Of Director Appointment

Pacific Edge Limited (PEB:NZX) has today advised that David Levison’s appointment as a Director has been confirmed, effective as at 2 April 2016.

David is a US-based Director, with an indepth knowledge and experience in the US healthcare market. He is currently CEO and a Director of CardioDx, a specialist molecular diagnostic company similar to Pacific Edge.

David is highly respected within the industry and has in market experience in building a successful medical diagnostics company in the US. His understanding of commercial molecular diagnostic products in the US healthcare market, will be of great value to Pacific Edge as it looks to expand in this region.

David will hold office until Pacific Edge’s next Annual Shareholders’ Meeting at which time he will offer himself for election by shareholders. The Board has determined that David Levison is an Independent Director, for the purposes of NZX Listing Rule 3.3.2.